Comunicación
Nº 027
Comunicación |
|
Sanchez Blas, Mercedes. Alvarez García, Augusto. Vazquez Martul, Eduardo.
|
|
1.- Starzl TE Discussion of Murray JE, Wilson RE, Tilney NL, et al. Five years experience in renal transplantation with inmunosuppresive drugs, supervival function, complications and the role of linphocite depletion by thoracic duct fistula. Ann Surg 1968: 416-35.
2.- Mc Khann CF: Primary malignancy in patients undergoing inmunosupression for renal transplantation 1969;8: 209-212.
3.- Penn I. Hammond W. Brettschneider L. Starzl TE: Malignant lynphomas in transplantation patients. Trasplant Proc 1969; 1: 106-112.
4.- Cockfield SM. Preiksaitis J. Harvey E. et al Sequential use of ALG and OKT3 in renal transplants associated with an increased incidence of fulminant posttransplant patients lymphoproliferative disorders?. Transplant Proc 1991; 23: 1106-07.
5.- Crawford DH. Thomas JA. Janossy G. et al Epstein-Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft. Lancer 1980; i: 1355-56.
6.- Nalesnik MA. Jadde R. Starzl TE. Demetris AJ. Porter K. Burnham JA et al The pathology of posttrasplant lymphoproliferative disorders ocurring in the setting of cyclosporine A-prednisone inmunosuppression. Am J Pathl 1988; 133: 173-192.
7.- Penn I. Cancers following cyclosporine therapy. Transplantation Proc 1987; 19 (pt 3): 2211-2213.
8.- Penn I. First MR Development and influence of cancer following cyclosporine therapy. Trasplantation Proc 1986; 18 (suppl 1): 210-213.
9.- Swinnen LJ. Constanzo-Nordin MR. Fisher SG. O SullivanEJ. Jonhson MR, Hereux Al et al al Increased incidence of lymphoproliferative disorder after inmunosupression with the monoclonal antibody OKT3 in cardiac transplant recipients. N. Engl J Med 1990; 323: 1723-28.
10.- Wilkinson AH: Smith JL. Hunsicker LG. Tobacman J. Kapelanski DP. Jhonson M et al. Increased frecuency of posttrasplant lymphoma in patients treated with cyclosporine, azothioprine and prednisone. Transplantation 1989 47: 293. .
11.- Opelz G. Henderson R. Incidence of non Hodking lynphoma in kidney and heart transplant recipients. Lancet 1993; 342: 1514-16.
12.- Degiannis-D. Hornung N Possible association between the observed cyclosporine induce up regulation of in vitro inmune functions and posttransplantation lymphoproliferative disorders. J Heart Lung transplantation 1994; Nov Dec 13(6): 1145-6.
13.- Oda-D; Persson-GR. Haigh-WG. Sabath-DE; Penn-I. Aziz-S Oral presentation of posttrasplantation lyproproliferative disorders. An unusual manifestation. Transplantation 1996-Feb15; 61 (3): 435-40.
14.- Knowles DM, Cesarman E. Chadburn A, Frizzera G. Chen J.Rose E. A et al. Correlative morphologic and molecular genetic analysis demostrates three distinct categories of posttransplantation lyphoproliferative disorders. Blood 1995; vol 85 nº 2 (january 15): 552-565.
15.- Bragg DG. Chor PJ. Murray KA Kjeldsberg CR Lyproliferative disorders of the lung Histopathology, clinical manifestations and imagins features. Am J. Roentgenol 1994; Aug 163 (2) : 273-81.
16.- Caignan S. Staples CA Muller NL Intrathoratic lyphoprolifertive disorders in the inmunocompromised patient CT findings. Radiology 1995; oct; 197(1): 53-8.
17.- Cleary ML Nalesnik MA. Shearer W. Sklar J. Clonal analysis of transplant asocciated lymphoproliferations based on the structure of the genomic termini of the Epstein Barr virus. Blood 1988; 72: 349-52.
18.- Cohen JL Epstein Barr virus lymphoproliferative disease associated with accquired inmunodeficiency. Medicine 1991; 70: 137-170.
19.- Hanto DW. Frizzera G. Gajl-Peczalska KF Sakamoto K Portillo DT Balfour MM et all Epstein Barr virus induced B cell limphoma after renal transplantation: Acyclovir therapy and transition from polyclonal to monoclonal B cell proliferation. New Engl J Med 1982; 306: 913-918.
20.- Hanto DW. Frizzera G. Gajl.-Peczalka K J Simmons RL Epstein-Barr virus inmunodeficiency and B cell lymphoproliferation. Transplantation 1985; 39: 461-472.
21.- Frank D. Cesarman E. Liu-YF. Michler RE. Knowles DM. Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein Barr virus.Blood 1995; Mar 1: 1396-403.
22.- Cleary ML. Warnke R. Sklar J: Clonal analysis of transplant associated lymphoprolifertions based on the structure oj the genomic termini of the structure of the Epstein Barr virus associated lymphoproliferations of diverse clonal origins after bone marrow transplantation in a 12 year old patients with severe combined inmunodeficiency. N Engl J Med 1985; 312: 1151, 1985.
23.- Delecluse HJ. Kremmer E. Rouault JP. Cuor C.Bornkamm G Berger F. The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-trasplant lyphoproliferative disorders Am. J. Pathol 1995; 146: 1113-20.
24.- Rooney CM. Loftin SK. Holladay MS. Brenner HK. Krance RA. Heslop He. Early identification of Epstein Barr virus associated post trasplantation lymphoproliferative disease. Br J. Haematol 1995; 89: 98-103.
25.- Berg LC. Copenhaver CM. Morrison VA.Gruber SA. Dunn DL Gajl-Peczalska K. et al B cell lymphoproliferative disorders in solid organ transplant patients: detection of Epstein Barr virus by in situ hybridation. Hum Pathol 1992 Feb; 23 (2): 159-63.
26.- Chetty R. Biddolph S. Gatter K Bcl- 2 Epstein-Barr virus latent membrane protein EBNA-1 and EBNA-2 staining in posttransplantation lymphoproliferative disorders. Blood 1996; Jun 15 87 (12): 5395
27.- Boyle MJ. Sewll WA. Sculley TB. Apolloni A. Turner JJ. Swanson CE. Et al Subtypes of Epstein Barr virus in human inmunodeficiency virus associated non Hodking´s lymphoma. Blood 1991; 78:3004-11.
28.- D´Amore ES. Manivel JC. Gafl-Peczaska KJ el al B cell lymphoproliferative disorders after bone marrow transplant An analysis of 10 cases with emphasis on Epstein Barr virus detection by in situ hybridation. Cancer 1991; 68:1285-1295.
29.- Young L. Alfieri C. Hennessy K et al Expression of Epstein-Barr virus trasformation associated genes in tissues of patients with EBV lympropoliferative disease. N Engl J Med 1989; 321: 1080-1085.
30.- Thomas JA. Hotchin NA. Allday MJ. et al Inmunohistology of EBV associated antigens in B cell disorders from inmunocompromised individuals. Transplantation 1990; 49: 944-953.
31.- Randhawa PS. Yousem SA. Epstein Barr virus associated lymproliferative disease in a heart-lung allograft. Transplantation 1990; 49: 126-130.
32.- Zutter MM. Martin PJ. Sale GE et al Epstein Barr virus lymphoproliferation after bone marrow transplantation. Blood 1988; 72: 520-529.
33.- Harris NL. Ferry JA. Swerdlow SH. Posttransplant lymphoproliferative disorders: Summary of society for hematopathology workshop.Seminars in diagnostic pathology 1997; 14, nº1 (february) : 8-14.
34.- Shapiro RS Mc Clain K. Frizzera G et al Epsteim-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 1988; 71:1234-1243.
35.- Penn I The changing pattern of posttransplant malignancies. Transplant Proc 1991;23:1101-03.
36.- Craig F E. Gulley ML. Banks PM Postransplantation lymphoproliferative disorders. Am J Clin Pathol 1993; 99 nº 3 (march) :265-276.
37.- Chadburn A. Cesarman E. Yi Fang Liu. YF Addonizio L. Hsu D. Michler RE et al Molecular genetic analysis demostrates that multiple posttransplantation lymphoproliferative disorders occurring in one anatomic site in a single patient represent distinct primary limphoid neoplasms.Cancer 1995; 75: 2747-56.
38.- Castro CJ. Klimo P. Worth A Multifocal aggresive lyphoma of the gastrointestinal tract in a renal transplant patient treated with cyclosporin A and prednisone. Cancer 1985;55: 1665-1667.
39.- Cleary ML. Sklar J. Lympropoliferative disorders in cardiac transplant recipients are multiclonal lymphomas. Lancet 1984; 2: 489-493.
40.- Weissmann DJ. Ferry JA. Harris NL. Louis DN, Delmonico I. Spiro I.Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggresive tumors of host origin. Am J Clin Pathol 1995; 103 : 748-755
41.- Hjelle B Evans-Holm M. Yen TSB et al A poorly diferentiated lymphoma of donor
|
|
